On NPR’s All Things Considered, Sydney Lupkin asked DrugPatentWatch if drug patents could be used to identify injector pens which could then be swapped to fix drug shortages. Referring to…
The post NPR and DrugPatentWatch – Can drug injector pens be sw…
NPR and DrugPatentWatch – Can drug injector pens be swapped? Read Post »
This article was originally published by Jiayi Chen, Zhifeng Zhao, Xinyu Wang and Jingjun Huang in Drug Repurposing – Advances, Scopes and Opportunities in Drug Discovery and is republished here…
The post Utilizing 505(b)(2) Regulatory Pathway for New …
This is a guest post by Oleksandr Topachevskyi at Digital Health Outcomes. Oleksandr may be contacted at [email protected] Commercial, nonprofit, and government companies are quite good at calculating the costs…
The post Social Return on Investment a…
This article was originally published by Guy Shtar, Louise Azulay, Omer Nizri, Lior Rokach & Bracha Shapira in Scientific Data volume 9, Article number: 263 under a Creative Commons Attribution…
The post CDCDB: A large and continuously updated drug com…
CDCDB: A large and continuously updated drug combination database Read Post »
DrugPatentWatch has been named to Genetic Engineering News‘ Best of the Web list. The review by Genetic Engineering News profile highlighted the “new training modules designed to help you find…
The post DrugPatentWatch named “Best of the Web” by Geneti…
DrugPatentWatch named “Best of the Web” by Genetic Engineering News Read Post »
DrugPatentWatch publisher Yali Friedman, Ph.D. will be speaking at the 15th Edition Pharma Resource Planning and Portfolio Optimization Conference. The event is from from April 25-26, 2022 at the Sheraton…
The post Join DrugPatentWatch at the 15th Phar…
This is a guest post by Ray Miller and Megan E. Bowers, Ph.D. at DLA Piper. Ray may be contacted at [email protected]. When it comes to protecting therapeutic assets, I…
The post The value of method of use patent claims in protecting your the…
The value of method of use patent claims in protecting your therapeutic assets Read Post »
FEATURED ARTICLE Branded Generics Promise Profits for Drugmakers, Peace of Mind for Patients Developing nations offer welcoming and growing markets as Abbott focuses exclusively on reformulating and marketing off-patent medications…
The post DrugPatent…
Drugs contain ingredients with therapeutic activity, so-called “active ingredients” as well as inactive ingredients. These inactive ingredients, called excipients, are included in oral products for various reasons, such as to…
The post 2 Strategies to …
2 Strategies to Grow Your Excipient Business by Tracking Drug Patents Read Post »
DrugPatentWatch developed this course to help users better understand the complexities and common strategies around brand erosion and generic entry. The positive responses received made it apparent that the course…
The post Free Online Course on Drug P…
Free Online Course on Drug Patents, Generic and Branded Drugs Read Post »